- Home
- PMCB vs PT Comparison
PMCB vs PT Comparison
Compare PMCB & PT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMCB
- PT
- Stock Information
- Founded
- PMCB 1996
- PT 2012
- Country
- PMCB United States
- PT China
- Employees
- PMCB N/A
- PT 70
- Industry
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- PT Computer Software: Programming Data Processing
- Sector
- PMCB Health Care
- PT Technology
- Exchange
- PMCB Nasdaq
- PT Nasdaq
- Market Cap
- PMCB 15.8M
- PT 14.8M
- IPO Year
- PMCB N/A
- PT 2018
- Fundamental
- Price
- PMCB $1.77
- PT $0.93
- Analyst Decision
- PMCB
- PT
- Analyst Count
- PMCB 0
- PT 0
- Target Price
- PMCB N/A
- PT N/A
- AVG Volume (30 Days)
- PMCB 37.4K
- PT 32.3K
- Earning Date
- PMCB 09-17-2024
- PT 04-30-2024
- Dividend Yield
- PMCB N/A
- PT N/A
- EPS Growth
- PMCB N/A
- PT N/A
- EPS
- PMCB 0.54
- PT N/A
- Revenue
- PMCB N/A
- PT $7,434,458.00
- Revenue This Year
- PMCB N/A
- PT N/A
- Revenue Next Year
- PMCB N/A
- PT N/A
- P/E Ratio
- PMCB $3.23
- PT N/A
- Revenue Growth
- PMCB N/A
- PT N/A
- 52 Week Low
- PMCB $1.39
- PT $0.71
- 52 Week High
- PMCB $2.58
- PT $1.38
- Technical
- Relative Strength Index (RSI)
- PMCB 48.90
- PT 39.94
- Support Level
- PMCB $1.72
- PT $0.76
- Resistance Level
- PMCB $2.06
- PT $1.12
- Average True Range (ATR)
- PMCB 0.28
- PT 0.09
- MACD
- PMCB -0.00
- PT -0.01
- Stochastic Oscillator
- PMCB 38.24
- PT 45.83
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
About PT Pintec Technology Holdings Limited
Pintec Technology Holdings Ltd is a technology platform that provides financial services in China in terms of loan volume facilitated. The company connects business partners and financial partners on its open platform and enables them to provide financial services to end-users. Its products include installment loans, personal loans, wealth management, insurance brokerage, SME loans, and others. The company generates its revenue from technical service fees also by providing financing for these borrowers and earn installment service fees, They earn wealth management services fees and commission on financial products.